An­oth­er SPAC is gear­ing up to go pub­lic, this time com­ing from Oleg Nodel­man's EcoR1 Cap­i­tal

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

It’s an­oth­er week in the biotech in­dus­try, which …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER